e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 6, 2005
Biogen Idec Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
0-19311
(Commission
File Number)
|
|
33-0112644
(I.R.S. Employer
Identification No.) |
| |
|
|
14 Cambridge Center, Cambridge, Massachusetts
(Address of principal executive offices)
|
|
02142
(Zip Code) |
Registrant’s telephone number, including area code: (617) 679-2000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 1.01 Entry into a Material Definitive Agreement
The Registrant is in discussion with William H. Rastetter, the Registrant’s Executive
Chairman, regarding severance arrangements.
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers.
On December 7, 2005, the Registrant announced that William H. Rastetter, the Registrant’s
Executive Chairman, will retire from that position effective the end of the
year. Dr. Rastetter is also resigning as a director of the Registrant effective
the end of the year. Effective as
of January 1, 2006, the Registrant’s Chief Executive Officer, James C. Mullen, will assume Dr.
Rastetter’s executive duties. The Board has elected Bruce Ross, currently a director of the
Registrant, as its non-executive Chairman of the Board effective as of January 1, 2006.
A copy of the press release announcing Dr. Rastetter’s retirement is attached hereto as
Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
99.1 Press Release issued by Biogen Idec Inc. dated December 7, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
Biogen Idec Inc.
|
|
| |
By: |
/s/ Raymond G. Arner
|
|
| |
|
Raymond G. Arner |
|
| |
|
Acting General Counsel |
|
| |
Date: December 12, 2005
EXHIBIT INDEX
| |
|
|
|
|
| Exhibit |
|
|
| Number |
|
Description of Exhibit |
| |
|
|
|
|
| |
99.1 |
|
|
Press Release issued by Biogen Idec Inc. dated December 7, 2005. |